• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

    12.43 +0.20 (+1.64%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,470,439
    Open 12.28
    Bid (Size) 12.35 (500)
    Ask (Size) 12.40 (3,500)
    Prev. Close 12.23
    Today's Range 12.08 - 12.45
    52wk Range 10.07 - 19.69
    Shares Outstanding 71,355,872
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Agility to Host Analyst & Investor Day on October 6, 2026
    From Agility Robotics
    Via Business Wire
    News headline image
    Agility Robotics to Attend Upcoming Investor Conferences
    From Agility Robotics
    Via Business Wire

    Performance

    YTD
    +21.2%
    +21.2%
    1 Month
    -14.0%
    -14.0%
    3 Month
    -0.1%
    -0.1%
    6 Month
    +22.6%
    +22.6%
    1 Year
    +21.2%
    +21.2%

    More News

    Read More
    News headline image
    Agility Robotics and Churchill Capital Corp XI Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
    From Agility Robotics, Inc.
    Via Business Wire
    News headline image
    Grounded: SpaceX Stumbles as Grok Fails to Ignite ↗
    Via MarketBeat
    Topics Artificial Intelligence
    Unusual volume stocks are being observed in Monday's session. ↗
    Via Chartmill
    Unusual volume stocks in Thursday's session ↗
    Via Chartmill
    News headline image
    Agility Robotics’ SPAC Deal Opens a Rare Door Into Humanoid AI ↗
    Via MarketBeat
    Topics Artificial Intelligence ETFs
    On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    These stocks have an unusual volume in today's session ↗
    Via Chartmill
    News headline image
    Agility Robotics to Go Public Through $2.5 Billion Merger with Churchill Capital Corp XI
    From Agility Robotics, Inc.
    Via Business Wire
    News headline image
    Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share ↗
    Via Benzinga
    News headline image
    How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market ↗
    Via Benzinga
    News headline image
    ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
    From ChemoCentryx, Inc.
    Via GlobeNewswire
    News headline image
    Biotech Stocks Well-Positioned For The Fourth Quarter ↗
    Via Talk Markets
    News headline image
    ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    From ChemoCentryx, Inc.
    Via GlobeNewswire
    News headline image
    These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗
    Via Talk Markets
    News headline image
    Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year ↗
    Via Investor's Business Daily
    News headline image
    Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗
    Via Investor's Business Daily
    News headline image
    INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
    From Scott+Scott Attorneys at Law LLP
    Via Business Wire
    News headline image
    7 Dow Stocks With Superior Fundamentals ↗
    Via InvestorPlace
    News headline image
    Healthcare Sector Still Looks Good But Lacks Momentum ↗
    Via Talk Markets
    News headline image
    ChemoCentryx's Return On Capital Employed Insights ↗
    Via Benzinga

    Frequently Asked Questions

    Is Churchill Capital Corp XI - Class A Ordinary Shares publicly traded?
    Yes, Churchill Capital Corp XI - Class A Ordinary Shares is publicly traded.
    What exchange does Churchill Capital Corp XI - Class A Ordinary Shares trade on?
    Churchill Capital Corp XI - Class A Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Churchill Capital Corp XI - Class A Ordinary Shares?
    The ticker symbol for Churchill Capital Corp XI - Class A Ordinary Shares is CCXI on the Nasdaq Stock Market
    What is the current price of Churchill Capital Corp XI - Class A Ordinary Shares?
    The current price of Churchill Capital Corp XI - Class A Ordinary Shares is 12.43
    When was Churchill Capital Corp XI - Class A Ordinary Shares last traded?
    The last trade of Churchill Capital Corp XI - Class A Ordinary Shares was at 09/25/26 04:00 PM ET
    What is the market capitalization of Churchill Capital Corp XI - Class A Ordinary Shares?
    The market capitalization of Churchill Capital Corp XI - Class A Ordinary Shares is 886.95M
    How many shares of Churchill Capital Corp XI - Class A Ordinary Shares are outstanding?
    Churchill Capital Corp XI - Class A Ordinary Shares has 887M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.